NCT07599670

A Study to Assess the Safety and Effects of ABBV-1758 Following Subcutaneous or Intravenous Injections in Participants With Alzheimer's Disease

RecruitingPHASE1, PHASE2INTERVENTIONAL

Trial Details

Start: 2026-05-15Est. Completion: 2030-04

Enrollment target: 210 participants

Locations

Irvine Center for Clinical Research /ID# 277752, Irvine, California, United States
Alpine Clinical Research Center - Boulder - 47th Street /ID# 277856, Boulder, Colorado, United States
Key Clinical Research LLC /ID# 277800, Bradenton, Florida, United States
K2 Medical Research - Clermont /ID# 277859, Clermont, Florida, United States
K2 Medical Research - The Villages /ID# 278290, Lady Lake, Florida, United States
Alzheimer'S Research And Treatment Center - Stuart /ID# 278206, Stuart, Florida, United States
Alzheimer's Research And Treatment Center - Wellington /ID# 277749, Wellington, Florida, United States
Conquest Research - Winter Park /ID# 277760, Winter Park, Florida, United States
Adams Clinical /ID# 277754, Watertown, Massachusetts, United States
Neurology Clinic - Cordova /ID# 277790, Cordova, Tennessee, United States

Contact

Mild Cognitive ImpairmentAlzheimer DiseaseDementia

The Alzheimer's Disease Neuroimaging Initiative 4 (ADNI4) is a non-randomized, longitudinal, natural history study desig…

Birmingham, United StatesCompleted Jul 31, 2027

Mild Cognitive Impairment

This is a double-blind, randomized controlled trial designed to test the effects of cannabidiol (CBD) on validated bioma…

Aurora, United StatesEst. completion Apr 2028

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.